CORRESP Filing
GeoVax Labs, Inc.
Date: June 25, 2025 · CIK: 0000832489 · Accession: 0001437749-25-021232
AI Filing Summary & Sentiment
File numbers found in text: 333-288085
Show Raw Text
CORRESP 1 filename1.htm govx20250625_corresp.htm GeoVax Labs, Inc. 1900 Lake Park Drive Suite 380 Smyrna, Georgia 30080 (678) 384-7220 June 25, 2025 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 Re: GeoVax Labs, Inc. Registration Statement on Form S-1 File No. 333-288085 Ladies and Gentlemen: Reference is made to (i) the letter (the “Company Letter”) dated June 17, 2025, as amended, from GeoVax Labs, Inc., a Delaware corporation (the “Registrant”), to the Division of Corporation Finance whereby the Registrant requested effectiveness of the above-captioned registration statement. The Registrant hereby withdraws the request set forth in the Company Letter. If you have any questions or comments, please contact me or if you prefer, you may contact our counsel, F. Reid Avett of Womble Bond Dickinson (US) LLP, by telephone at (202) 857-4425, or by email at reid.avett@wbd-us.com. Very truly yours, GeoVax Labs, Inc. By: /s/ Mark W. Reynolds Mark W. Reynolds Chief Financial Officer